Astrazeneca Vaccine
- All
- News
- Videos
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
- Thursday May 16, 2024
- India News | Indo-Asian News Service
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
- www.ndtv.com
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
- Thursday May 16, 2024
- World News | Indo-Asian News Service
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
- www.ndtv.com
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
- Tuesday May 14, 2024
- World News | Edited by Bhavya Sukheja
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
- www.ndtv.com
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
- Friday May 10, 2024
- India News | Press Trust of India
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | Reported by Vishnu Som
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | NDTV News Desk
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
AstraZeneca Drops Covid Vaccine Weeks After Rare Side Effect Report
- Wednesday May 8, 2024
- World News | Edited by Muskaan Sharma
AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine, days after it was reported that the British pharmaceutical company admitted that the jab can cause rare side effects.
- www.ndtv.com
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
- Monday May 6, 2024
- India News | Reported by Ashish Bhargava
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
- www.ndtv.com
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
- Friday May 3, 2024
- India News | NDTV News Desk
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
- www.ndtv.com
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
- Thursday May 2, 2024
- India News | NDTV Newsdesk
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
- www.ndtv.com
-
Fact Check: Are Indians Who Got Covishield Vaccine Susceptible To TTS?
- Wednesday May 1, 2024
- Science | THIP Media
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
- www.ndtv.com
-
"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects Concerns
- Wednesday May 1, 2024
- World News | Edited by Samiran Mishra
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its commitment to patient safety.
- www.ndtv.com
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
- Tuesday April 30, 2024
- India News | Indo-Asian News Service
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
- www.ndtv.com
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
- Tuesday April 30, 2024
- World News | Edited by NDTV News Desk
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
- www.ndtv.com
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
- Thursday May 16, 2024
- India News | Indo-Asian News Service
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
- www.ndtv.com
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
- Thursday May 16, 2024
- World News | Indo-Asian News Service
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
- www.ndtv.com
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
- Tuesday May 14, 2024
- World News | Edited by Bhavya Sukheja
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
- www.ndtv.com
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
- Friday May 10, 2024
- India News | Press Trust of India
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | Reported by Vishnu Som
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | NDTV News Desk
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
AstraZeneca Drops Covid Vaccine Weeks After Rare Side Effect Report
- Wednesday May 8, 2024
- World News | Edited by Muskaan Sharma
AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine, days after it was reported that the British pharmaceutical company admitted that the jab can cause rare side effects.
- www.ndtv.com
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
- Monday May 6, 2024
- India News | Reported by Ashish Bhargava
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
- www.ndtv.com
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
- Friday May 3, 2024
- India News | NDTV News Desk
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
- www.ndtv.com
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
- Thursday May 2, 2024
- India News | NDTV Newsdesk
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
- www.ndtv.com
-
Fact Check: Are Indians Who Got Covishield Vaccine Susceptible To TTS?
- Wednesday May 1, 2024
- Science | THIP Media
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
- www.ndtv.com
-
"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects Concerns
- Wednesday May 1, 2024
- World News | Edited by Samiran Mishra
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its commitment to patient safety.
- www.ndtv.com
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
- Tuesday April 30, 2024
- India News | Indo-Asian News Service
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
- www.ndtv.com
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
- Tuesday April 30, 2024
- World News | Edited by NDTV News Desk
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
- www.ndtv.com